Panbela Therapeutics Inc (PBLA) stock has fallen -99.63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PBLA stock a score of 29 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. PBLA's rank also includes a short-term technical score of 9.
PBLA has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on PBLA!
Panbela Therapeutics Inc (PBLA) stock has gained 25.62% while the S&P 500 is higher by 0.28% as of 12:30 PM on Wednesday, Nov 29. PBLA is higher by $0.13 from the previous closing price of $0.51 on volume of 1,557,621 shares. Over the past year the S&P 500 has gained 15.41% while PBLA has fallen -99.63%. PBLA lost -$178.23 per share in the over the last 12 months.
Click Here to get the full Stock Report for Panbela Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
